chr18-62161173-C-A
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_176787.5(PIGN):c.181G>T(p.Glu61*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,613,408 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_176787.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- multiple congenital anomalies-hypotonia-seizures syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, ClinGen, PanelApp Australia
- Fryns syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_176787.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PIGN | NM_176787.5 | MANE Select | c.181G>T | p.Glu61* | stop_gained | Exon 4 of 31 | NP_789744.1 | ||
| PIGN | NM_001438896.1 | c.181G>T | p.Glu61* | stop_gained | Exon 4 of 32 | NP_001425825.1 | |||
| PIGN | NM_012327.6 | c.181G>T | p.Glu61* | stop_gained | Exon 3 of 30 | NP_036459.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PIGN | ENST00000640252.2 | TSL:1 MANE Select | c.181G>T | p.Glu61* | stop_gained | Exon 4 of 31 | ENSP00000492233.1 | ||
| PIGN | ENST00000400334.7 | TSL:1 | c.181G>T | p.Glu61* | stop_gained | Exon 3 of 30 | ENSP00000383188.2 | ||
| PIGN | ENST00000638424.1 | TSL:5 | n.181G>T | non_coding_transcript_exon | Exon 2 of 29 | ENSP00000491963.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152146Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000803 AC: 2AN: 248942 AF XY: 0.00000741 show subpopulations
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461262Hom.: 0 Cov.: 30 AF XY: 0.0000165 AC XY: 12AN XY: 726872 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152146Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74328 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:2
The E61X variant in the PIGN gene has not been reported previously as a pathogenic variant nor as abenign variant, to our knowledge. This variant is predicted to cause loss of normal protein functioneither through protein truncation or nonsense-mediated mRNA decay. The E61X variant was notobserved at a significant frequency in approximately 6100 individuals of European and AfricanAmerican ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret E61X as a pathogenic variant.
Multiple congenital anomalies-hypotonia-seizures syndrome 1 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Glu61*) in the PIGN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PIGN are known to be pathogenic (PMID: 24253414, 27038415). This variant is present in population databases (rs200199765, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with PIGN-related conditions (PMID: 29096607). ClinVar contains an entry for this variant (Variation ID: 373038). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at